← Leaderboards
Luke O. Russell
Vyriad, Inc.
$866,638
Attributed
$1,733,276
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $909.4K · FY2019–20$1M$750K$500K$250K$0
'19
'20
Funding mix
By agency
NIH$1,733,276 · 2
By mechanism
R44$1,733,276 · 2
Top collaborators
- Shruthi Naik2 shared
Most similar at Vyriad, Inc.
Same institution · by research overlap
- Rosa Maria Diaz$979,046
- Bradley C. Leibovich$360,531
- Shruthi Naik$866,638
Others in their field
Other Emerging Leaders on “Measurable”
- Kimberly Smith · Ppd Development Lp$115,671,664
- Peter K Fritschel · California Institute Of Technology$78,820,000
- Yunda Huang · Fred Hutchinson Cancer Center$53,797,542
- Susan M Landau · University Of California Berkeley$47,252,026
- John Hobbs · Suny At Stony Brook$41,857,417
- Christopher Bee · Suny At Stony Brook$41,239,084
Research focus
MeasurableSafetyDoseMalignant NeoplasmsOncolyticResponseClinicDisease ProgressionImmune Checkpoint InhibitorIntravenousMonitorNeoplastic CellOncolytic VirotherapyQuality Of LifeCessation Of LifeCheckpoint TherapyCancer EtiologyClinical TrialsEffective TherapyEngineeringImmune ResponseImmunotherapyMediatingSafety And Feasibility